Anti-fibrotic macrophage cell therapy(Carisma Therapeutics)

N/A

Report date: 2024/06/14 17:39:22

Base Information

Drug NameAnti-fibrotic macrophage cell therapy(Carisma Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCarisma Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCarisma Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A